These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18180491)

  • 1. Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients.
    Landrum MB; Meara ER; Chandra A; Guadagnoli E; Keating NL
    Health Aff (Millwood); 2008; 27(1):159-68. PubMed ID: 18180491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost of cancer care in the United States: a work very much in progress.
    Lipscomb J
    J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences among the elderly in the treatment costs of colorectal cancer: how important is race?
    Wright GE; Barlow WE; Green P; Baldwin LM; Taplin SH
    Med Care; 2007 May; 45(5):420-30. PubMed ID: 17446828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
    Chen CT; Li L; Brooks G; Hassett M; Schrag D
    Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
    Soneji S; Yang J
    Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
    Zuckerman RB; Stearns SC; Sheingold SH
    J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases.
    Stuart B; Shoemaker JS; Dai M; Davidoff AJ
    Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's Been The Bang For The Buck? Cost-Effectiveness Of Health Care Spending Across Selected Conditions In The US.
    Wamble D; Ciarametaro M; Houghton K; Ajmera M; Dubois RW
    Health Aff (Millwood); 2019 Jan; 38(1):68-75. PubMed ID: 30615530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD; Berry K; Etzioni R
    Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic and social characteristics and spending at the end of life.
    Shugarman LR; Decker SL; Bercovitz A
    J Pain Symptom Manage; 2009 Jul; 38(1):15-26. PubMed ID: 19615623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.